Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
St. Jude Children's Research Hospital
Research
ARPA-H awards up to $160M for custom genetic medicines
The most notable recipient is the Children’s Hospital of Philadelphia, which treated baby KJ with a ground-breaking custom gene therapy last year.
Darren Incorvaia
Jul 10, 2026 4:00am
'Special' CAR-T target works in solid tumors, but limits remain
Nov 28, 2023 9:00am
CARs fine-tuned with an anchor protein work against solid tumors
Feb 6, 2023 1:05pm
Novavax CEO to retire after 12 years—Chutes & Ladders
Jan 13, 2023 9:30am
AZ, FibroGen's roxadustat holds promise for sickle cell disease
Oct 18, 2022 7:05am
Manipulating T-cell fate to improve CAR-T in solid tumors
Jun 24, 2022 9:20am
